NRP1 and hepatocellular carcinoma: More importantly, NRP-1 expression associates with the advanced stage of disease, and negatively correlates with the prognosis of hepatocellular carcinoma [2], colorectal cancer [3], and esophagus squamous cell carcinoma [4], indicating that NRP-1 is a potential molecular target for cancer therapy.